UBS Group AG - ORTHO CLINICAL DIAGNOSTICS H ownership

ORTHO CLINICAL DIAGNOSTICS H's ticker is OCDX and the CUSIP is G6829J107. A total of 1 filers reported holding ORTHO CLINICAL DIAGNOSTICS H in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ORTHO CLINICAL DIAGNOSTICS H
ValueSharesWeighting
Q1 2022$7,966,000
+41.0%
426,885
+61.6%
0.00%
+50.0%
Q4 2021$5,649,000
+25.0%
264,092
+8.0%
0.00%
+100.0%
Q3 2021$4,520,000
+13.1%
244,592
+31.1%
0.00%0.0%
Q2 2021$3,995,000
-0.6%
186,605
-10.4%
0.00%0.0%
Q1 2021$4,019,000208,3000.00%
Other shareholders
ORTHO CLINICAL DIAGNOSTICS H shareholders Q2 2022
NameSharesValueWeighting ↓
Carlyle Group Inc. 143,406,000$3,070,322,00020.78%
SECTORAL ASSET MANAGEMENT INC 1,286,750$27,549,0002.23%
SHAPIRO CAPITAL MANAGEMENT LLC 5,566,581$119,180,0002.07%
Eversept Partners, LP 1,394,284$29,851,6201.99%
CRAMER ROSENTHAL MCGLYNN LLC 1,683,200$36,037,0001.16%
ARMISTICE CAPITAL, LLC 1,672,000$35,798,0000.64%
Alyeska Investment Group, L.P. 2,436,189$52,159,0000.60%
Ghisallo Capital Management LLC 426,864$9,139,0000.35%
BRANT POINT INVESTMENT MANAGEMENT LLC 155,000$3,319,0000.31%
Polar Asset Management Partners Inc. 1,275,196$27,302,0000.28%
View complete list of ORTHO CLINICAL DIAGNOSTICS H shareholders